BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 16956653)

  • 1. A case of squamous cell lung carcinoma with high concentration of parathyroid hormone-related peptide in serum and pleural effusion presenting hypercalcemia.
    Iguchi H; Katakami H; Ichinose Y; Nishi Y; Tanaka S; Hara N; Ohta M; Haji M; Nawata H
    Jpn J Cancer Res; 1993 Apr; 84(4):419-24. PubMed ID: 8514608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of parathyroid hormone-related protein mRNA in tumors obtained from patients with humoral hypercalcemia of malignancy.
    Honda S; Yamaguchi K; Suzuki M; Sato Y; Adachi I; Kimura S; Abe K
    Jpn J Cancer Res; 1988 Jun; 79(6):677-81. PubMed ID: 3137193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Hypercalcemia from PTHrP-Producing Fibromyxoid Sarcoma Responsive to Glucocorticoid Therapy.
    Niu I; Hsiao EC; Wustrack R; Wysolmerski JJ; Dann P; Masharani U
    Calcif Tissue Int; 2023 Aug; 113(2):246-253. PubMed ID: 37358786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid Hormone Related Peptide Hypercalcemia as a Presentation of Endometrial Clear Cell Carcinoma.
    Georges C; Adhikari B; Koundaveety S; Jones R; Paudel K; Haas C
    J Community Hosp Intern Med Perspect; 2023; 13(6):67-70. PubMed ID: 38596557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Fibroblast Growth Factor Receptor Fusion-Positive Intrahepatic Cholangiocarcinoma With Humoral Hypercalcemia of Malignancy.
    Chauhan A; Likasitwatanakul P; Ahmed A; Sibley SD
    Cureus; 2024 Apr; 16(4):e58741. PubMed ID: 38779292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholangiocarcinoma Presenting as Humoral Hypercalcemia of Malignancy: A Case Report and Literature Review.
    Erdinc B; Ramachandran P; Yadav R; Sahni S; Joseph G
    Cureus; 2019 Dec; 11(12):e6481. PubMed ID: 32025405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral hypercalcemia of pregnancy treated with bisphosphonates.
    Koren R; Neeman O; Koren S; Benbassat CA
    Arch Endocrinol Metab; 2018 Feb; 62(1):125-128. PubMed ID: 29694631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis.
    Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M
    Cancer Imaging; 2016 Feb; 16():3. PubMed ID: 26873307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral hypercalcemia in patients with colorectal carcinoma: report of two cases and review of the literature.
    Lortholary AH; Cadeau SD; Bertrand GM; Guerin-Meyer VI; Gamelin EC; Audran MJ
    Cancer; 1999 Dec; 86(11):2217-21. PubMed ID: 10590360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral hypercalcemia of malignancy. The role of parathyroid hormone-related protein.
    Insogna KL
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):779-94. PubMed ID: 2673773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercalcemia induced by ovarian clear cell carcinoma producing all transcriptional variants of parathyroid hormone-related peptide gene during pregnancy.
    Hwang CS; Park SY; Yu SH; Park JY; Park CT; Han KO
    Gynecol Oncol; 2006 Nov; 103(2):740-4. PubMed ID: 16956653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcemia due to parathyroid hormone-related protein produced by primary ovarian clear cell adenocarcinoma: case report.
    Tsunematsu R; Saito T; Iguchi H; Fukuda T; Tsukamoto N
    Gynecol Oncol; 2000 Feb; 76(2):218-22. PubMed ID: 10637074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone-related protein as a potential tumor marker: a case report of ovarian clear cell carcinoma.
    Suwaki N; Masuyama H; Mizutani Y; Kodama J; Hiramatsu Y
    J Obstet Gynaecol Res; 2006 Feb; 32(1):94-8. PubMed ID: 16445533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
    Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.